|
HELB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.856700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.907730E-02 |
| Normal-vs-Stage2 |
2.142200E-02 |
| Normal-vs-Stage3 |
8.737600E-02 |
| Normal-vs-Stage4 |
3.202600E-01 |
| Stage1-vs-Stage2 |
2.354800E-01 |
| Stage1-vs-Stage3 |
9.111200E-01 |
| Stage1-vs-Stage4 |
4.667000E-01 |
| Stage2-vs-Stage3 |
2.859400E-01 |
| Stage2-vs-Stage4 |
1.434800E-01 |
| Stage3-vs-Stage4 |
5.990200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.276300E-03 |
| Normal-vs-AfricanAmerican |
6.224800E-01 |
| Normal-vs-Asian |
9.155700E-02 |
| Caucasian-vs-AfricanAmerican |
1.247770E-02 |
| Caucasian-vs-Asian |
1.185810E-01 |
| AfricanAmerican-vs-Asian |
9.098300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.170200E-02 |
| Normal-vs-Female |
1.306350E-02 |
| Male-vs-Female |
6.505400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.963200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.243200E-03 |
| Normal-vs-Age(61-80Yrs) |
4.215700E-02 |
| Normal-vs-Age(81-100Yrs) |
7.912000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.428800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.046200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.419200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.991800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.216400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.394200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.931440E-01 |
| Normal-vs-Grade 2 |
1.045520E-02 |
| Normal-vs-Grade 3 |
3.458300E-02 |
| Normal-vs-Grade 4 |
1.600570E-01 |
| Grade 1-vs-Grade 2 |
7.335600E-01 |
| Grade 1-vs-Grade 3 |
5.786200E-01 |
| Grade 1-vs-Grade 4 |
6.270400E-01 |
| Grade 2-vs-Grade 3 |
6.157000E-01 |
| Grade 2-vs-Grade 4 |
7.120000E-01 |
| Grade 3-vs-Grade 4 |
9.811000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.590400E-04 |
| Normal-vs-ccB subtype |
4.565500E-02 |
| ccA subtype-vs-ccB subtype |
1.427790E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.082300E-03 |
| Normal-vs-N1 |
3.949000E-01 |
| N0-vs-N1 |
8.862000E-01 |
|
|
